News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
195
Sources here
16
Companies here
14
Search results Stored financial headlines

Active search

195 matching headlines

Ticker or company: MINDMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

MNDO|Mind CTI Ltd|Price:1.020|Chg%:+0.040

Mind CTI Ltd (MNDO) is currently priced at $1.020, up 4.12%, with a market cap of $20.78M and a P/E TTM of 6.99. The company's fundamentals are considered healthy with high growth potential, and its valuation is deemed fairly valued within the Software & …

MNDO main company
Sharemaestro market context Price below Trend Line 52 weeks -12.1% MNDO stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MIND|Mind Technology Inc|Price:5.510|Chg%:+0.010

Mind Technology Inc. (MIND) closed at $5.55 with a slight gain. The company's fundamentals are stable with high growth potential, and it is considered fairly valued within the Oil & Gas Related Equipment and Services industry. Analysts rate MIND as a Strong Buy with …

MIND main company
Sharemaestro market context Price below Trend Line 52 weeks -57.7% MIND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Shareholders at MIND Technology (NASDAQ: MIND) approve directors, plan and auditor

MIND Technology, Inc. shareholders at the 2026 Virtual Annual Meeting re-elected five directors, approved an amendment to the Stock Awards Plan adding 400,000 shares, and ratified Baker Tilly US, LLP as the independent registered public accounting firm. They also gave advisory approval for Named …

MIND main company
Sharemaestro market context Price below Trend Line 52 weeks -57.7% MIND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Walleye Capital LLC Has $3.92 Million Holdings in Bright Minds Biosciences Inc. $DRUG

Walleye Capital LLC significantly increased its stake in Bright Minds Biosciences Inc. (NASDAQ:DRUG) by 108% in the first quarter, now holding 53,706 shares valued at $3.92 million. Other institutional investors also boosted their positions, with hedge funds and institutions collectively owning 40.52% of the …

DRUG main company
Sharemaestro market context Price below Trend Line 52 weeks +73.9% · Next-week setup negative 43.1% DRUG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bright Minds Biosciences (NASDAQ:DRUG) Upgraded at Zacks Research

Zacks Research has upgraded Bright Minds Biosciences (NASDAQ:DRUG) from "hold" to "strong-buy," contributing to a consensus "Buy" rating among analysts with a target price of $143.83. This upgrade follows the company's recent strong quarterly earnings report, where its EPS of ($0.80) surpassed estimates of …

DRUG main company
Sharemaestro market context Price below Trend Line 52 weeks +73.9% · Next-week setup negative 43.1% DRUG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

MIND stock holds its ground as Mind Technology awaits new catalyst

Mind Technology (MIND) stock is awaiting a new catalyst, with the latest company context focusing on its financial metrics. For the quarter ended January 31, 2026, the company reported $13.5 million in revenue, a gross profit of $2.1 million, and a net loss of …

MIND main company
Sharemaestro market context Price below Trend Line 52 weeks -57.7% MIND stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Bright Minds Biosciences (NASDAQ:DRUG) Shares Up 5% - Should You Buy?

Bright Minds Biosciences (NASDAQ:DRUG) shares increased by 5% on Friday, reaching $79.16 with below-average trading volume. The company has a "Moderate Buy" consensus rating from analysts with an average price target of $143.83, and recently surpassed EPS estimates. Insider and institutional ownership remains significant, …

DRUG main company
Sharemaestro market context Price below Trend Line 52 weeks +73.9% · Next-week setup negative 43.1% DRUG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context